Skip to content

Startups

Fate Therapeutics

Sectors
Health & Medicine

Launched
01/01/2009

Description

Fate Therapeutics is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life‑threatening diseases.

Team Members

Christian Weyer

President and CEO

Dan Shoemaker

Chief Research Officer

Scott Wolchko

Chief Operating & Financial Officer

Moya Daniels

VP of Regulatory Affairs and Quality Assurance

Randall Moon

Co-founder, William and Marilyn Connor Chair and Founding Director of the Institute for Stem Cell and Regenerative Medicine at University of Washington and Howard Hughes Medical Institute Investigator